Similarities between List of investigational hormonal agents and Telapristone
List of investigational hormonal agents and Telapristone have 5 things in common (in Unionpedia): Breast cancer, Endometriosis, Onapristone, Selective progesterone receptor modulator, Uterine fibroid.
Breast cancer
Breast cancer is cancer that develops from breast tissue.
Breast cancer and List of investigational hormonal agents · Breast cancer and Telapristone ·
Endometriosis
Endometriosis is a condition in which the endometrium, the layer of tissue that normally covers the inside of the uterus, grows outside of it.
Endometriosis and List of investigational hormonal agents · Endometriosis and Telapristone ·
Onapristone
Onapristone (INN) (developmental code names ZK-89299, ZK-299) is a synthetic, steroidal antiprogestogen with additional antiglucocorticoid activity which was developed by Schering and described in 1984 but was never marketed.
List of investigational hormonal agents and Onapristone · Onapristone and Telapristone ·
Selective progesterone receptor modulator
A selective progesterone receptor modulator (SPRM) is an agent that acts on the progesterone receptor.
List of investigational hormonal agents and Selective progesterone receptor modulator · Selective progesterone receptor modulator and Telapristone ·
Uterine fibroid
Uterine fibroids, also known as uterine leiomyomas or fibroids, are benign smooth muscle tumors of the uterus.
List of investigational hormonal agents and Uterine fibroid · Telapristone and Uterine fibroid ·
The list above answers the following questions
- What List of investigational hormonal agents and Telapristone have in common
- What are the similarities between List of investigational hormonal agents and Telapristone
List of investigational hormonal agents and Telapristone Comparison
List of investigational hormonal agents has 85 relations, while Telapristone has 15. As they have in common 5, the Jaccard index is 5.00% = 5 / (85 + 15).
References
This article shows the relationship between List of investigational hormonal agents and Telapristone. To access each article from which the information was extracted, please visit: